Learn More
Medchemexpress LLC Vatinoxan (hydrochloride) | 130466-38-5 | 99.8% | 454.97 | 50 MG

Supplier: Medchemexpress LLC HY19057A50MG
Vatinoxan hydrochloride is a peripheral α2 adrenergic receptor antagonist. It is for research use only and may be useful in attenuating reductions in heart rate.
- Increases cardiac index and tissue oxygen delivery without adverse effects.
- Attenuates or prevents dexmedetomidine's systemic hemodynamic effects in a dose-dependent manner.
- Induces the least alterations in cardiovascular function at a 50:1 dose ratio (Vatinoxan:dexmedetomidine).
- Attenuates bradycardia associated with dexmedetomidine.
- Shortens sedative effect without altering its quality.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.